Detalhe da pesquisa
1.
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
J Allergy Clin Immunol
; 151(2): 485-493.e11, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309122
2.
Low bone mass and hypovitaminosis D in haemophilia: A single-centre study in patients with severe and moderate haemophilia A and B.
Haemophilia
; 26(5): 898-906, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842167
3.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol
; 95(2): 156-166, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721282
4.
Is pharmacological thromboprophylaxis necessary in persons with haemophilia undergoing major orthopaedic surgery?
Haemophilia
; 30(3): 865-867, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575529
5.
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
Am J Hematol
; 94(8): 845-852, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056768
6.
Inhibitors in Nonsevere Hemophilia A: What Is Known and Searching for the Unknown.
Semin Thromb Hemost
; 44(6): 568-577, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439277
7.
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
Future Oncol
; 14(26): 2713-2723, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207489
8.
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms.
Am J Hematol
; 92(2): 187-195, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27880982
9.
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.
Blood
; 123(10): 1552-5, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371211
10.
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.
Blood
; 123(14): 2157-60, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458439
11.
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.
Blood
; 123(12): 1833-5, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443442
12.
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood
; 124(7): 1062-9, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986690
13.
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.
Blood
; 124(16): 2507-13; quiz 2615, 2014 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037629
14.
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
Am J Hematol
; 91(9): 918-22, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264006
15.
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
Am J Hematol
; 91(7): 681-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037840
16.
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
Am J Hematol
; 91(7): 692-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060898
17.
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
Haematologica
; 100(6): 757-67, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840601
18.
Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis.
Am J Hematol
; 90(5): 434-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683038
19.
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.
Cancer
; 120(4): 513-20, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24258498
20.
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
Br J Haematol
; 167(4): 541-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25130523